Generation of Secretable and Nonsecretable Interleukin 15 Isoforms Through Alternate Usage of Signal Peptides

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1998 Feb 7

PMID 9405632

Citations 58

Authors

Y Tagaya

G Kurys

T A Thies

J M Losi

N Azimi

J A Hanover

R N Bamford

T A Waldmann

Affiliations

Soon will be listed here.

Abstract

Two isoforms of human interleukin 15 (IL-15) exist. One isoform has a shorter putative signal peptide (21 amino acids) and its transcript shows a tissue distribution pattern that is distinct from that of the alternative IL-15 isoform with a 48-aa signal peptide. The 21-aa signal isoform is preferentially expressed in tissues such as testis and thymus. Experiments using different combinations of signal peptides and mature proteins (IL-2, IL-15, and green fluorescent protein) showed that the short signal peptide regulates the fate of the mature protein by controlling the intracellular trafficking to nonendoplasmic reticulum sites, whereas the long signal peptide both regulates the rate of protein translation and functions as a secretory signal peptide. As a consequence, the IL-15 associated with the short signal peptide is not secreted, but rather is stored intracellularly, appearing in the nucleus and cytoplasmic components. Such production of an intracellular lymphokine is not typical of other soluble interleukin systems, suggesting a biological function for IL-15 as an intracellular molecule.

Citing Articles

IL-15 transpresentation by ovarian cancer cells improves CD34 progenitor-derived NK cell's anti-tumor functionality.

Vidal-Manrique M, Nieuwenstein T, Hooijmaijers L, de Jonge P, Djojoatmo M, Jansen J Oncoimmunology. 2025; 14(1):2465010.

PMID: 39960378 PMC: 11834524. DOI: 10.1080/2162402X.2025.2465010.

IL-1β Induces Human Endothelial Surface Expression of IL-15 by Relieving let-7c-3p Suppression of Protein Translation.

Mullan C, Summer L, Lopez-Giraldez F, Tobiasova Z, Manes T, Yasothan S J Immunol. 2024; 213(9):1338-1348.

PMID: 39302113 PMC: 11493510. DOI: 10.4049/jimmunol.2400331.

Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy.

Hu S, Meng K, Wang T, Qu R, Wang B, Xi Y Biomark Res. 2024; 12(1):40.

PMID: 38637902 PMC: 11027539. DOI: 10.1186/s40364-024-00586-w.

Signalling mechanisms driving homeostatic and inflammatory effects of interleukin-15 on tissue lymphocytes.

Skariah N, James O, Swamy M Discov Immunol. 2024; 3(1):kyae002.

PMID: 38405398 PMC: 10883678. DOI: 10.1093/discim/kyae002.

IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of .

Nandi M, Moyo M, Orkhis S, Mobulakani J, Limoges M, Rexhepi F Front Immunol. 2021; 12:793918.

PMID: 34956227 PMC: 8703170. DOI: 10.3389/fimmu.2021.793918.

References

Acland P, Dixon M, Peters G, Dickson C . Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon. Nature. 1990; 343(6259):662-5. DOI: 10.1038/343662a0. View

Kozak M . The scanning model for translation: an update. J Cell Biol. 1989; 108(2):229-41. PMC: 2115416. DOI: 10.1083/jcb.108.2.229. View

Grabstein K, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V . Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994; 264(5161):965-8. DOI: 10.1126/science.8178155. View

Burton J, Bamford R, Peters C, Grant A, Kurys G, Goldman C . A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A. 1994; 91(11):4935-9. PMC: 43904. DOI: 10.1073/pnas.91.11.4935. View

Bamford R, Grant A, Burton J, Peters C, Kurys G, Goldman C . The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A. 1994; 91(11):4940-4. PMC: 43905. DOI: 10.1073/pnas.91.11.4940. View

Giri J, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S . Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994; 13(12):2822-30. PMC: 395163. DOI: 10.1002/j.1460-2075.1994.tb06576.x. View

Anderson D, Johnson L, Glaccum M, Copeland N, Gilbert D, Jenkins N . Chromosomal assignment and genomic structure of Il15. Genomics. 1995; 25(3):701-6. DOI: 10.1016/0888-7543(95)80013-c. View

Giri J, Kumaki S, Ahdieh M, Friend D, Loomis A, Shanebeck K . Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 1995; 14(15):3654-63. PMC: 394440. DOI: 10.1002/j.1460-2075.1995.tb00035.x. View

Bamford R, Battiata A, Burton J, Sharma H, Waldmann T . Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc Natl Acad Sci U S A. 1996; 93(7):2897-902. PMC: 39731. DOI: 10.1073/pnas.93.7.2897. View

10.

Tagaya Y, Bamford R, DeFilippis A, Waldmann T . IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 1996; 4(4):329-36. DOI: 10.1016/s1074-7613(00)80246-0. View

11.

Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, Orengo A . Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene. 1996; 12(10):2187-92. View

12.

Mrozek E, Anderson P, Caligiuri M . Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 1996; 87(7):2632-40. View

13.

Kirman I, Nielsen O . Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am J Gastroenterol. 1996; 91(9):1789-94. View

14.

Tagaya Y, Burton J, Miyamoto Y, Waldmann T . Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J. 1996; 15(18):4928-39. PMC: 452230. View

15.

Puzanov I, Bennett M, Kumar V . IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol. 1996; 157(10):4282-5. View

16.

Onu A, Pohl T, Krause H, Bulfone-Paus S . Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol. 1997; 158(1):255-62. View

17.

Jullien D, Sieling P, Uyemura K, Mar N, Rea T, Modlin R . IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol. 1997; 158(2):800-6. View

18.

McInnes I, Leung B, Sturrock R, Field M, Liew F . Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med. 1997; 3(2):189-95. DOI: 10.1038/nm0297-189. View

19.

Carson W, Fehniger T, Haldar S, Eckhert K, Lindemann M, Lai C . A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest. 1997; 99(5):937-43. PMC: 507901. DOI: 10.1172/JCI119258. View

20.

Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, Pereno R . Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur J Immunol. 1997; 27(5):1049-54. DOI: 10.1002/eji.1830270502. View